• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病患者中抗氧化修饰低密度脂蛋白(LDL)自身抗体的意义。

The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasis.

作者信息

Orem A, Cimşit G, Değer O, Orem C, Vanizor B

机构信息

Department of Biochemistry, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.

出版信息

Clin Chim Acta. 1999 Jun 15;284(1):81-8. doi: 10.1016/s0009-8981(99)00062-5.

DOI:10.1016/s0009-8981(99)00062-5
PMID:10437645
Abstract

Psoriasis is associated with changes in plasma lipid and lipoproteins, which may play a role in the development of occlusive vascular disease. The oxidation of low-density lipoprotein (LDL) is considered a key event in the development and progression of atherosclerosis. Autoantibodies against oxidized LDL (auAb-oxLDL) may contribute to understanding the relationship between oxidative processes and development of atherosclerosis. Thirty-three patients with psoriasis and 30 matched control subjects were investigated. LDL oxidation was evaluated as the presence of autoantibodies against LDL oxidatively modified with Cu++, by an ELISA system in the patients and control sera. AuAb-ox LDL levels of the patients were found to be significantly increased compared with a control group. 42% of the patients and 3.3% of the control subjects had higher auAb-ox LDL levels than the cut-off point (352 mU/ml). The levels of auAb-ox LDL were found to be correlated with PASI score (r = 0.67, p < 0.01). Also, The antibody level was found to be correlated with polymorphonuclear elastase and alpha-1 antitrypsin levels (r = 0.58, p < 0.05; r = 0.51, p < 0.05, respectively). It was concluded that increased levels of auAb-oxLDL in the psoriatic patients may be a consequence of the interaction between imbalance of oxidant-antioxidant system and lipoproteins, and the measurement of auAb-oxLDL in the patients may mirror in vivo occurrence of oxidative processes.

摘要

银屑病与血浆脂质和脂蛋白的变化有关,这些变化可能在闭塞性血管疾病的发生中起作用。低密度脂蛋白(LDL)的氧化被认为是动脉粥样硬化发生和发展的关键事件。抗氧化型LDL自身抗体(auAb-oxLDL)可能有助于理解氧化过程与动脉粥样硬化发展之间的关系。对33例银屑病患者和30例匹配的对照受试者进行了研究。通过ELISA系统检测患者和对照血清中针对用Cu++氧化修饰的LDL的自身抗体,以此评估LDL氧化情况。发现患者的auAb-ox LDL水平与对照组相比显著升高。42%的患者和3.3%的对照受试者的auAb-ox LDL水平高于临界值(352 mU/ml)。发现auAb-ox LDL水平与银屑病面积和严重程度指数(PASI)评分相关(r = 0.67,p < 0.01)。此外,还发现抗体水平与多形核弹性蛋白酶和α-1抗胰蛋白酶水平相关(分别为r = 0.58,p < 0.05;r = 0.51,p < 0.05)。得出的结论是,银屑病患者中auAb-oxLDL水平升高可能是氧化-抗氧化系统与脂蛋白失衡相互作用的结果,检测患者的auAb-oxLDL可能反映体内氧化过程的发生情况。

相似文献

1
The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasis.银屑病患者中抗氧化修饰低密度脂蛋白(LDL)自身抗体的意义。
Clin Chim Acta. 1999 Jun 15;284(1):81-8. doi: 10.1016/s0009-8981(99)00062-5.
2
The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies: relationship with low-density lipoprotein oxidation and plasma total antioxidant status.降脂治疗对低密度脂蛋白自身抗体的影响:与低密度脂蛋白氧化及血浆总抗氧化状态的关系。
Coron Artery Dis. 2002 Feb;13(1):65-71. doi: 10.1097/00019501-200202000-00009.
3
The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behçet's disease.白塞病患者中抗氧化修饰低密度脂蛋白(LDL)自身抗体的评估、LDL的氧化易感性、血脂和脂质过氧化氢水平、总抗氧化状态、抗氧化酶活性以及内皮功能障碍。
Clin Biochem. 2002 May;35(3):217-24. doi: 10.1016/s0009-9120(02)00290-4.
4
Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis.银屑病患者脂质和脂蛋白含量的致动脉粥样硬化倾向及其与氧化-抗氧化系统关系的评估
Clin Chim Acta. 2003 Feb;328(1-2):71-82. doi: 10.1016/s0009-8981(02)00373-x.
5
Autoantibodies against oxidatively modified low-density lipoprotein in patients with Behçet's disease.白塞病患者体内针对氧化修饰低密度脂蛋白的自身抗体。
Dermatology. 1999;198(3):243-6. doi: 10.1159/000018122.
6
Autoantibodies against oxidized LDL and serum total antioxidant status in active cyclists and ex-cyclists.现役自行车运动员和退役自行车运动员体内抗氧化型低密度脂蛋白自身抗体及血清总抗氧化状态
Horm Metab Res. 2003 Sep;35(9):541-5. doi: 10.1055/s-2003-42656.
7
Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients.银屑病患者的血浆同型半胱氨酸及其与动脉粥样硬化血栓形成标志物的关系。
Clin Chim Acta. 2003 Jun;332(1-2):23-30. doi: 10.1016/s0009-8981(03)00082-2.
8
Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM.非胰岛素依赖型糖尿病患者中针对氧化修饰低密度脂蛋白的自身抗体
Diabetes. 1995 Jan;44(1):60-6. doi: 10.2337/diab.44.1.60.
9
Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.原发性高血压患者体内抗氧化修饰低密度脂蛋白自身抗体的存在:体内低密度脂蛋白氧化增强的生化特征。
J Hypertens. 1995 Jan;13(1):129-38.
10
Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus.抗氧化型低密度脂蛋白自身抗体不能预测非胰岛素依赖型糖尿病患者的动脉粥样硬化性血管疾病。
Arterioscler Thromb Vasc Biol. 1996 Oct;16(10):1236-42. doi: 10.1161/01.atv.16.10.1236.

引用本文的文献

1
Psoriasis, stem cells, and obesity: metabolic exploration for therapeutics.银屑病、干细胞与肥胖:治疗的代谢探索
J Med Life. 2025 Jul;18(7):608-620. doi: 10.25122/jml-2025-0033.
2
Overview of Clinical Relevance of Antibodies Against Oxidized Low-Density Lipoprotein (oLAb) Within Three Decades by ELISA Technology.酶联免疫吸附测定技术在三个十年内对氧化型低密度脂蛋白抗体(oLAb)临床相关性的概述
Antioxidants (Basel). 2024 Dec 19;13(12):1560. doi: 10.3390/antiox13121560.
3
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside.
靶向前蛋白转化酶枯草溶菌素 9(PCSK9):从实验室到临床。
Signal Transduct Target Ther. 2024 Jan 8;9(1):13. doi: 10.1038/s41392-023-01690-3.
4
The relationship between blood lipid and risk of psoriasis: univariable and multivariable Mendelian randomization analysis.血脂与银屑病风险的关系:单变量和多变量孟德尔随机分析。
Front Immunol. 2023 Jun 22;14:1174998. doi: 10.3389/fimmu.2023.1174998. eCollection 2023.
5
Oxidized low-density lipoprotein associates with cardiovascular disease by a vicious cycle of atherosclerosis and inflammation: A systematic review and meta-analysis.氧化型低密度脂蛋白通过动脉粥样硬化和炎症的恶性循环与心血管疾病相关联:一项系统评价和荟萃分析。
Front Cardiovasc Med. 2023 Jan 16;9:1023651. doi: 10.3389/fcvm.2022.1023651. eCollection 2022.
6
The role of proprotein convertase subtilisin/kexin type 9 (PCSK9) in the pathophysiology of psoriasis and systemic lupus erythematosus.前蛋白转化酶枯草溶菌素/克尔新9型(PCSK9)在银屑病和系统性红斑狼疮病理生理学中的作用。
Postepy Dermatol Alergol. 2022 Aug;39(4):645-650. doi: 10.5114/ada.2022.118919. Epub 2022 Sep 1.
7
Methotrexate Decreases the Level of PCSK9-A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data.甲氨蝶呤可降低银屑病患者中前致动脉粥样硬化血脂谱风险的新型指标——前蛋白转化酶枯草溶菌素9(PCSK9)的水平:初步数据
J Clin Med. 2020 Mar 26;9(4):910. doi: 10.3390/jcm9040910.
8
Is the Ratio of Antibodies Against Oxidized LDL to Oxidized LDL an Indicator of Cardiovascular Risk in Psoriasis?抗氧化型低密度脂蛋白抗体与氧化型低密度脂蛋白的比值是否为银屑病心血管风险的指标?
Oman Med J. 2016 Sep;31(5):390-3. doi: 10.5001/omj.2016.78.
9
Plasma total antioxidant capacity and peroxidation biomarkers in psoriasis.银屑病患者的血浆总抗氧化能力及过氧化生物标志物
J Biomed Sci. 2016 Jul 4;23(1):52. doi: 10.1186/s12929-016-0268-x.
10
Lipid disturbances in psoriasis: an update.银屑病中的脂质紊乱:最新进展。
Mediators Inflamm. 2010;2010. doi: 10.1155/2010/535612. Epub 2010 Jul 20.